Calyxt completes $10.9 million placement of Common Stock and Warrants

Client(s) Calyxt, Inc.

Jones Day represented Calyxt, Inc. in connection with the placement to an institutional investor in an underwritten offering of 3,880,000 shares of its Common Stock, pre-funded warrants to purchase up to 3,880,000 shares of its Common Stock, and Common Warrants to purchase up to 7,760,000 shares of its Common Stock.

Calyxt intends to use the net proceeds from the offering for enhancing the capabilities of its BioFactory production system and increasing its capacity to produce at larger scales, continuing to build out its PlantSpring technology platform and artificial intelligence/machine learning capabilities, furthering customer relationships, and for working capital and general corporate purposes.